GIUSTINA, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 22.582
AS - Asia 9.558
EU - Europa 7.588
SA - Sud America 1.670
AF - Africa 198
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 22
Totale 41.642
Nazione #
US - Stati Uniti d'America 22.337
CN - Cina 3.517
SG - Singapore 3.135
UA - Ucraina 2.589
BR - Brasile 1.385
HK - Hong Kong 1.197
DE - Germania 1.061
PL - Polonia 781
FR - Francia 715
FI - Finlandia 622
VN - Vietnam 534
GB - Regno Unito 453
TR - Turchia 375
IT - Italia 374
IE - Irlanda 372
RU - Federazione Russa 363
IN - India 292
CA - Canada 142
BD - Bangladesh 125
AR - Argentina 90
ZA - Sudafrica 68
MX - Messico 62
IQ - Iraq 60
SE - Svezia 54
EC - Ecuador 50
JP - Giappone 42
ID - Indonesia 41
NG - Nigeria 37
ES - Italia 35
PY - Paraguay 35
SA - Arabia Saudita 34
NL - Olanda 33
PK - Pakistan 33
CO - Colombia 28
MA - Marocco 28
BE - Belgio 27
CZ - Repubblica Ceca 27
CL - Cile 25
IR - Iran 25
VE - Venezuela 24
UZ - Uzbekistan 23
AU - Australia 22
EU - Europa 20
PE - Perù 20
AE - Emirati Arabi Uniti 19
AT - Austria 17
NP - Nepal 14
KE - Kenya 13
JM - Giamaica 12
JO - Giordania 12
AZ - Azerbaigian 11
IL - Israele 9
DZ - Algeria 8
ET - Etiopia 8
KZ - Kazakistan 8
LT - Lituania 8
PT - Portogallo 8
RO - Romania 8
TN - Tunisia 8
UY - Uruguay 7
EG - Egitto 6
HN - Honduras 6
KR - Corea 6
MY - Malesia 6
OM - Oman 6
BO - Bolivia 5
CH - Svizzera 5
MU - Mauritius 5
PH - Filippine 5
AL - Albania 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
EE - Estonia 4
LV - Lettonia 4
PA - Panama 4
TH - Thailandia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BY - Bielorussia 3
CM - Camerun 3
DK - Danimarca 3
GE - Georgia 3
LB - Libano 3
NI - Nicaragua 3
RS - Serbia 3
SN - Senegal 3
SV - El Salvador 3
AM - Armenia 2
BW - Botswana 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
ML - Mali 2
MN - Mongolia 2
NO - Norvegia 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 41.621
Città #
Fairfield 3.211
Woodbridge 2.448
Ashburn 1.980
Houston 1.756
Jacksonville 1.741
Singapore 1.667
Cambridge 1.303
Ann Arbor 1.282
Seattle 1.222
Hong Kong 1.188
Wilmington 1.112
Warsaw 771
Princeton 689
Nanjing 637
Beijing 633
The Dalles 625
San Jose 580
Chandler 515
Dublin 370
New York 326
Lauterbourg 303
Istanbul 298
Helsinki 266
Nanchang 256
Los Angeles 248
Moscow 201
Des Moines 187
Ho Chi Minh City 184
Shenyang 167
Buffalo 159
Changsha 142
San Diego 131
Hebei 127
São Paulo 119
Hanoi 116
Tianjin 116
Jiaxing 112
Milan 106
Redondo Beach 104
Munich 80
Shanghai 75
Chicago 74
Kunming 72
Jinan 68
San Francisco 66
Dallas 64
Brescia 62
Orem 59
Hangzhou 50
Council Bluffs 49
Dearborn 49
Verona 49
Santa Clara 47
Lancaster 44
London 44
Rio de Janeiro 42
Tokyo 42
Toronto 40
Abuja 37
Lanzhou 37
San Mateo 37
Johannesburg 35
Kocaeli 35
Chennai 34
Brooklyn 33
Guangzhou 33
Haikou 33
Montreal 33
Zhengzhou 32
Atlanta 30
Turku 30
Belo Horizonte 29
Manchester 29
Ningbo 29
Phoenix 29
Boardman 28
Dong Ket 28
Leawood 28
Mexico City 28
Dhaka 27
Denver 25
Brussels 24
Poplar 24
Augusta 23
Porto Alegre 22
Taizhou 22
Brasília 21
Curitiba 21
Quito 21
Brno 20
Stockholm 20
Da Nang 19
Mumbai 19
Tashkent 19
Ankara 18
Ardabil 18
Changchun 18
Baghdad 17
Biên Hòa 17
Boston 17
Totale 29.573
Nome #
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 353
Elevated intraocular pressure in patients with acromegaly 342
Ghrelin regulates proliferation and differentiation of osteoblastic cells 272
Guidelines for acromegaly management. 228
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. 226
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 203
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 193
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 193
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 193
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 190
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 189
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 189
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 187
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 183
Growth hormone deficiency in treated acromegaly 181
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 177
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 173
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 173
Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. 167
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 166
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. 165
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 163
Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells 162
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 158
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals 157
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. 155
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 155
Diagnosis and treatment of acromegaly complications. 152
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 152
A consensus on criteria for cure of acromegaly. 152
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. 152
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. 152
The management of the patient with acromegaly and headache: a still open clinical challenge. 150
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. 150
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 150
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 148
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. 148
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 148
A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients. 147
Guidelines for acromegaly management: an update. 146
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. 146
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 145
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 145
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cell 144
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study. 144
Cardiovascular risk in aging and obesity: is there a role for GH. 144
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. 143
Growth hormone deficiency in the adult. 143
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 143
High prevalence of radiological vertebral fractures in HIV-infected males 143
Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. 143
Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells 143
Long-term Picotamide, a dual thromboxane inhibitor, decreases both the urinary excretion of thromboxane B2 (TXB2) and albumin in patients with type 2 diabetes. 141
Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? 141
Acromegalic patients show the presence of hypertrophic remodelling of subcutaneous small resistance arteries 141
Ambulatory blood pressure monitoring (ABPM) in normotensive patients with acromegaly effect of 24-h continous infusion of octreotide. 141
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 140
Pituitary testing: a reappraisal. 140
A consensus on criteria for cure acromegaly 139
Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. 139
Prevalence of vertebral fractures in men with acromegaly 138
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 138
Expert consensus document:A consensus on the medical treatment of acromegaly 138
Octreotide for acromegaly treatment: a reappraisal. 138
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 138
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 137
[Effects of acute administration of nifedipine on exercise-induced microalbuminuria in normotensive patients with type 1 diabetes]. 137
CORTISOL AND THE MUSCLE-BONE AXIS:RESPONSE TO COMMENTS BY MOLFINO ET AL. 137
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 136
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis. 136
New understanding and treatments for osteoporosis. 136
New oral anticoagulants and pituitary apoplexy 136
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 136
Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart. 135
Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. 135
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 135
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 134
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 133
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. 133
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. 133
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients. 133
Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH-an update. 133
Growth hormone in glucocorticoid-induced osteoporosis. 132
Hypertrophic remodeling of subcutaneous small resistance arteries in acromegalic patients 132
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 132
Glucocorticoids and the regulation of growth hormone secretion. 132
TREATMENT OF HYPOTHYROIDISM:ALL THAT GLITTERS IS GOLD? 132
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 132
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 131
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 131
Leptin stimulates growth hormone secretion via a direct pituitary effect combined with a decreased somatostatin tone in a median eminence-pituitary perifusion study. 130
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. 130
Development of isolated ACTH deficiency in a man with type I diabetes mellitus. 130
Current guidelines for adult GH replacement. 129
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 129
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 129
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. 129
Influence of diabetes mellitus on vertebral fractures in men with acromegaly. 128
TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS. 128
Glucocorticoids and bone: cellular, metabolic and endocrine effects. 127
Totale 15.416
Categoria #
all - tutte 192.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021173 0 0 0 0 0 0 0 0 0 0 0 173
2021/20222.426 136 492 35 109 12 147 98 159 117 358 209 554
2022/20231.774 387 48 10 94 150 568 2 143 234 15 58 65
2023/20241.984 107 38 92 158 91 287 112 42 670 24 14 349
2024/20254.411 15 14 18 605 577 376 316 97 531 262 1.003 597
2025/20268.939 991 1.283 686 1.460 874 534 1.405 302 458 623 254 69
Totale 41.924